Phibro Animal Health | PAHC - Pre Tax Profit


Phibro Animal Health reported $4.84M in Pre-Tax Profit for its fiscal quarter ending in December of 2024.





Pre Tax Profit Change Date
Align Technology USD 176.6M 81.86M Dec/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Assertio Holdings USD -2.88M 648K Sep/2024
Aurora Cannabis CAD 46.98M 66.36M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -1.42M 39.82M Sep/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Henry Schein USD 137M 16M Sep/2025
Idexx Laboratories USD 306.98M 37.79M Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Merck USD 6.74B 22M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Pacira USD 9.52M 11.45M Sep/2025
Phibro Animal Health USD 4.84M 4.78M Dec/2024
Prestige Brands USD 69.13M 7.35M Sep/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Zoetis USD 887M 15M Sep/2025